Document is current

Article History

Accepted: 31 July 2025

First Online: 16 September 2025

Declarations

:

: Funding was provided by Pfizer Inc. and Astellas Pharma Inc.

: All authors have fully considered the Conflicts of Interest policy set forth by the journal. Alicia Morgans has received consulting fees from Astellas Pharma Inc., AAA Pharma Inc., AstraZeneca Pharma LP, Bayer HealthCare Pharma LLC, Curium, Janssen Pharma LLC, Exelixis Inc., Macrogenics, Myovant Sciences, Inc., Merck & Co. Inc., Novartis AG, Lantheus, Telix Pharma Limited, Sanofi S.A., and Pfizer Inc., research fees from Astellas, Bayer HealthCare Pharma LLC, Myovant Sciences Inc., and Pfizer Inc. Brooke Looney receives research support from AstraZeneca Inc. and Pfizer Inc. and has served as a speaker for AstraZeneca Inc. Jesse Mack is an employee of Astellas Pharma Inc. and was a consultant for Pfizer prior to joining Astellas Pharma Inc. Judeth Bianco is an employee of Pfizer Inc.

: This article does not contain any studies with human participants or animals by any of the authors.

: Not applicable, as this article does not contain any studies with human participants by any of the authors.

: All co-authors are aware of the submission to this journal, and agree to allow the corresponding author to serve as the primary correspondent with the editorial office and to review and sign off on the final proofs for publication.

: Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

: Code availability is not applicable as no software application or custom code was used, generated, or analyzed during the current study.

: All authors have contributed equally to the manuscript development (i.e., concept and planning of the work described; acquisition, analysis and interpretation of the data; critical review and revision of the manuscript; and approved the final submitted version of the manuscript). All authors read and approved the final version.

: Editorial support for this podcast was provided by Jack Liao, PhD, at Impact Communication Partners.